Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-25T01:12:11.090Z Has data issue: false hasContentIssue false

50 - An approach to the patient with motor neuron dysfunction

from Part IX - Motor neuron diseases

Published online by Cambridge University Press:  04 August 2010

M. Flint Beal
Affiliation:
Cornell University, New York
Anthony E. Lang
Affiliation:
University of Toronto
Albert C. Ludolph
Affiliation:
Universität Ulm, Germany
Matthew J. Parton
Affiliation:
Department of Neurology, The Institute of Psychiatry and Guy's, King's and St Thomas' School of Medicine, London, UK
P. Nigel Leigh
Affiliation:
Department of Neurology, The Institute of Psychiatry and Guy's, King's and St Thomas' School of Medicine, London, UK
Get access

Summary

Introduction

Anatomically, motor system dysfunction is defined as a derangement – either alone or in combination – of the pyramidal neurons of the corticospinal tract (upper motor neurons – UMN), brainstem motor nerve nuclei or spinal cord anterior horn cells (lower motor neurons – LMN). Both UMN and LMN lesions will cause muscle weakness, but other clinical features allow the two to be differentiated (a pyramidal pattern of weakness, spasticity and brisk reflexes follow UMN damage, whereas wasting, fasciculations and reduced or absent reflexes reflect LMN involvement).

A range of neurological conditions may cause a selective motor syndrome. Other illnesses will lead to such dysfunction, together with involvement of other body systems. Alternatively, some conditions will mimic a pure motor disorder but result from a non-selective disease process. These various diseases differ in their etiology, prognosis and management. It is therefore essential to evaluate patients presenting with motor neuron dysfunction carefully, and to make a firm diagnosis as early as possible. With early diagnosis, it is easier to organize effective care, and to keep the patient informed of likely developments in his or her condition.

In this chapter we will discuss the assessment of patients presenting with motor dysfunction and how this allows an accurate diagnosis to be made. We will also introduce and briefly review the principal disorders.

Clinical evaluation

History

The site that was first affected should be determined, as should the precise nature of the original symptom.

Type
Chapter
Information
Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 751 - 757
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bensimon, G., Lacomblez, L.et al. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med., 330, 585–91CrossRefGoogle ScholarPubMed
Chio, A., Finocchiaro, E.et al. (1999). Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology, 53, 1123–5CrossRefGoogle ScholarPubMed
Ellis, C. M., Simmons, A.et al. (1999). Distinct hyperintense MRI signal changes in the corticospinal tracts of a patient with motor neuron disease. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 1, pp. 41–4Google ScholarPubMed
Goodin, D. S., Rowley, H. A.et al. (1988). Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann. Neurol., 23, 418–20CrossRefGoogle ScholarPubMed
Hadano, S., Hand, C. K.et al. (2001). A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet., 29, 166–73CrossRefGoogle ScholarPubMed
Lacomblez, L., Bensimon, G.et al. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet, 347, 1425–31CrossRefGoogle ScholarPubMed
Lyall, R. A., Donaldson, N.et al. (2001). A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology, 57, 153–6CrossRefGoogle ScholarPubMed
Mazzini, L., Corra, T.et al. (1995). Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J. Neurol., 242, 695–8CrossRefGoogle ScholarPubMed
Miller, R. G., Rosenberg, J. A.et al. (1999). Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology, 52, 1311–23CrossRefGoogle ScholarPubMed
Newsom-Davis, I. C., Lyall, R. A.et al. (2001). The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J. Neurol., Neurosurg. Psychiatr., 71, 482–7CrossRefGoogle ScholarPubMed
Pinto, A. C., Evangelista, T.et al. (1995). Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J. Neurol. Sci., 129, 19–26CrossRefGoogle Scholar
Rosen, D. R., Siddique, T.et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62CrossRefGoogle ScholarPubMed
Shaw, C. E., Enayat, Z. E.et al. (1998). Mutations in all five exons of SOD-1 cause ALS. Ann. Neurol., 43, 390–4CrossRefGoogle ScholarPubMed
Thornton, F. J., Fotheringham, T.et al. (2002). Amyotrophic lateral sclerosis: enteral nutrition provision – endoscopic or radiologic gastrostomy? Radiology, 224, 713–17CrossRefGoogle ScholarPubMed
World Federation of Neurology Research Group on Motor Neuron Diseases (1998). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. http://www.wfnals.org/Articles/elescorial1998.htm
World Federation of Neurology Research Group on Neuromuscular Diseases (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124 (Suppl), 96–107CrossRef
Worwood, A. M. & Leigh, P. N. (1998). Indicators and prevalence of malnutrition in motor neurone disease. Eur. Neurol., 40, 159–63CrossRefGoogle ScholarPubMed
Yang, Y., Hentati, A.et al. (2001). The gene encoding alsin, a protein with three guanine–nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet., 29, 160–5CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×